Skip to main content
. 2018 Jun 20;9:647. doi: 10.3389/fphar.2018.00647

FIGURE 6.

FIGURE 6

18β-GA inhibits the activation of NFATc1 on osteoclastogenesis. (A) 18β-GA suppresses the binding of RANK and TRAF6. (B) 18β-GA had no significant effects on the expression of c-Fms mediated by M-CSF. However, the RANK expression was decreased by 18β-GA. (C) 18β-GA inhibits the mRNA levels of NFATc1. (D) 18β-GA inhibits osteoclastogenesis through NF-κB pathway and MAPK pathway of RANKL signaling.